Holen Sie sich die Stockscreener-App
0.00
100.00%
-0.1426
Schlusskurs vom Vortag:
$0.1426
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$7.90M
Einnahmen:
$3.10M
Nettoeinkommen (Verlust:
$-97.43M
KGV:
0.00
EPS:
-1.8
Netto-Cashflow:
$-94.38M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$3.015
Omega Therapeutics Inc Stock (OMGA) Company Profile
Firmenname
Omega Therapeutics Inc
Sektor
Branche
Telefon
(617) 949-4360
Adresse
140 FIRST STREET, SUITE 501, CAMBRIDGE
Vergleichen Sie OMGA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OMGA
Omega Therapeutics Inc
|
0.00 | 7.90M | 3.10M | -97.43M | -94.38M | -1.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
476.07 | 118.40B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.21 | 58.78B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
560.94 | 32.60B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
236.62 | 28.16B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
206.03 | 22.43B | 3.81B | -644.79M | -669.77M | -6.24 |
Omega Therapeutics Inc Stock (OMGA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-15 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-06-18 | Eingeleitet | Raymond James | Outperform |
| 2023-05-25 | Fortgesetzt | Jefferies | Buy |
| 2022-12-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-09-23 | Eingeleitet | Chardan Capital Markets | Buy |
Omega Therapeutics Inc Aktie (OMGA) Neueste Nachrichten
Recursion Pharmaceuticals (NASDAQ:RXRX) & Omega Therapeutics (NASDAQ:OMGA) Critical Analysis - Defense World
OMEGA THERAPEUTICS INC- The GF Score's 5 Key Aspects of Analysis - GuruFocus
Omega Therapeutics (OMGA) to Release Quarterly Earnings on Thursday - Defense World
Omega Therapeutics secures $9.8M in DIP financing - MSN
Layoff Tracker: GRO Biosciences Cuts Staff Amid Quest for Strategic Alternatives - BioSpace
Programmable mRNA therapeutics for controlled epigenomic modulation of single and multiplexed gene expression in diverse diseases - Nature
HilleVax (NASDAQ:HLVX) & Omega Therapeutics (NASDAQ:OMGA) Critical Survey - Defense World
Struggling healthcare firm files for Chapter 11 bankruptcy - TheStreet
OMEGA THERAPEUTICS INC Revenue Breakdown – OTC:OMGAQ - TradingView
Two new option listings and eighteen option delistings on February 25th - TipRanks
Omega Therapeutics to sell assets amid Nasdaq delisting By Investing.com - Investing.com South Africa
Omega Therapeutics to sell assets amid Nasdaq delisting - Investing.com
Volcon, Inc. and GlucoTrack, Inc. See Massive Gains, While Omega Therapeutics and Universe Pharmaceuticals Struggle - HPBL
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Finanzdaten der Omega Therapeutics Inc-Aktie (OMGA)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.97%
0.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):